Literature DB >> 26785402

Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults: Advice for High-Value Care From the American College of Physicians and the Centers for Disease Control and Prevention.

Aaron M Harris, Lauri A Hicks, Amir Qaseem.   

Abstract

BACKGROUND: Acute respiratory tract infection (ARTI) is the most common reason for antibiotic prescription in adults. Antibiotics are often inappropriately prescribed for patients with ARTI. This article presents best practices for antibiotic use in healthy adults (those without chronic lung disease or immunocompromising conditions) presenting with ARTI.
METHODS: A narrative literature review of evidence about appropriate antibiotic use for ARTI in adults was conducted. The most recent clinical guidelines from professional societies were complemented by meta-analyses, systematic reviews, and randomized clinical trials. To identify evidence-based articles, the Cochrane Library, PubMed, MEDLINE, and EMBASE were searched through September 2015 using the following Medical Subject Headings terms: "acute bronchitis," "respiratory tract infection," "pharyngitis," "rhinosinusitis," and "the common cold." HIGH-VALUE CARE ADVICE 1: Clinicians should not perform testing or initiate antibiotic therapy in patients with bronchitis unless pneumonia is suspected. HIGH-VALUE CARE ADVICE 2: Clinicians should test patients with symptoms suggestive of group A streptococcal pharyngitis (for example, persistent fevers, anterior cervical adenitis, and tonsillopharyngeal exudates or other appropriate combination of symptoms) by rapid antigen detection test and/or culture for group A Streptococcus. Clinicians should treat patients with antibiotics only if they have confirmed streptococcal pharyngitis. HIGH-VALUE CARE ADVICE 3: Clinicians should reserve antibiotic treatment for acute rhinosinusitis for patients with persistent symptoms for more than 10 days, onset of severe symptoms or signs of high fever (>39 °C) and purulent nasal discharge or facial pain lasting for at least 3 consecutive days, or onset of worsening symptoms following a typical viral illness that lasted 5 days that was initially improving (double sickening). HIGH-VALUE CARE ADVICE 4: Clinicians should not prescribe antibiotics for patients with the common cold.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26785402     DOI: 10.7326/M15-1840

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  97 in total

1.  Impact of Procalcitonin Guidance on Management of Adults Hospitalized with Chronic Obstructive Pulmonary Disease Exacerbations.

Authors:  Derek N Bremmer; Briana E DiSilvio; Crystal Hammer; Moeezullah Beg; Swati Vishwanathan; Daniel Speredelozzi; Matthew A Moffa; Kurt Hu; Rasha Abdulmassih; Jina T Makadia; Rikinder Sandhu; Mouhib Naddour; Noreen H Chan-Tompkins; Tamara L Trienski; Courtney Watson; Terrence J Obringer; Jim Kuzyck; Thomas L Walsh
Journal:  J Gen Intern Med       Date:  2018-02-05       Impact factor: 5.128

2.  Toward a Pellegrino-inspired theory of value in health care.

Authors:  Matthew DeCamp
Journal:  Theor Med Bioeth       Date:  2019-06

Review 3.  Peptoid drug discovery and optimization via surface X-ray scattering.

Authors:  Konstantin Andreev; Michael W Martynowycz; David Gidalevitz
Journal:  Biopolymers       Date:  2019-03-20       Impact factor: 2.505

Review 4.  National Action Plan on Antimicrobial Resistance (AMR) 2016-2020 and relevant activities in Japan.

Authors:  Norio Ohmagari
Journal:  Glob Health Med       Date:  2019-12-31

5.  Effect of a Health Care System Respiratory Fluoroquinolone Restriction Program To Alter Utilization and Impact Rates of Clostridium difficile Infection.

Authors:  Katherine M Shea; Athena L V Hobbs; Theresa C Jaso; Jack D Bissett; Christopher M Cruz; Elizabeth T Douglass; Kevin W Garey
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

6.  A decade of outpatient antimicrobial use in older adults in Ontario: a descriptive study.

Authors:  Charlie Tan; Erin Graves; Hong Lu; Anna Chen; Shudong Li; Kevin L Schwartz; Nick Daneman
Journal:  CMAJ Open       Date:  2017-12-21

7.  Improved Antibiotic Prescribing within a Veterans Affairs Primary Care System through a Multifaceted Intervention Centered on Peer Comparison of Overall Antibiotic Prescribing Rates.

Authors:  Nathan R Shively; Deanna J Buehrle; Marilyn M Wagener; Cornelius J Clancy; Brooke K Decker
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

8.  Attitudes of High Versus Low Antibiotic Prescribers in the Management of Upper Respiratory Tract Infections: a Mixed Methods Study.

Authors:  Aditi Patel; Elizabeth R Pfoh; Anita D Misra Hebert; Alexander Chaitoff; Aryeh Shapiro; Niyati Gupta; Michael B Rothberg
Journal:  J Gen Intern Med       Date:  2019-10-19       Impact factor: 5.128

9.  Patient Willingness to Have Tests to Guide Antibiotic Use for Respiratory Tract Infections: From the WWAMI Region Practice and Research Network (WPRN).

Authors:  Malaika Schwartz; Victoria Hardy; Gina A Keppel; William Alto; Jaime Hornecker; Beth Robitaille; Jon Neher; John Holmes; M Ashworth Dirac; Allison M Cole; Matthew Thompson
Journal:  J Am Board Fam Med       Date:  2017 Sep-Oct       Impact factor: 2.657

10.  Opportunities to Improve Fluoroquinolone Prescribing in the United States for Adult Ambulatory Care Visits.

Authors:  Sarah Kabbani; Adam L Hersh; Daniel J Shapiro; Katherine E Fleming-Dutra; Andrew T Pavia; Lauri A Hicks
Journal:  Clin Infect Dis       Date:  2018-06-18       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.